Published online before print April 15, 2002, doi: 10.1161/01.CIR.0000016182.85461.F4
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:2143.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
Influenza Vaccine Pilot Study in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions
The FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study
From Fundación Favaloro, Capital Federal, Buenos Aires, Argentina.
Correspondence to Enrique P. Gurfinkel, MD, PhD, Fundación Favaloro, Av Belgrano 1746 (1093), Capital Federal, Buenos Aires, Argentina. E-mail epgurfinkel{at}ffavaloro.org
Background— Recent reports have detected an increase in the number of patients with acute coronary syndromes during the flu season. In addition, the World Health Organization recommended vaccination against influenza infection for the Southern hemisphere in the winter of 2001.We evaluated the preventive impact of vaccination on subsequent ischemic events in myocardial infarction patients and in subjects undergoing planned percutaneous coronary angioplasty.
Methods and Results— We included 200 myocardial infarction patients admitted in the first 72 hours and 101 planned angioplasty/stent (PCI) patients without unstable coronary artery disease, prior bypass surgery, angioplasty, or tissue necrosis, in a prospective, multicenter log during the winter season. Infarct patients received a standard therapy and were then randomly allocated in a single-blind manner to either a unique intramuscular influenza vaccination or a control group. Similarly, PCI patients were allocated to either vaccination or control groups. Combined end points (death, reinfarction, and rehospitalization for ischemia) were assessed at 6 months’ follow-up. The first primary outcome, cardiovascular death, occurred in 2% of the patients in the vaccine group compared with 8% in the control group (relative risk with vaccine as compared with controls, 0.25; 95% CI 0.07 to 0.86; P=0.01). The triple composite end point occurred in 11% of the patients in the vaccine group compared with 23% in controls (P=0.009).
Conclusions— Influenza vaccination may reduce the risk of death and ischemic events in patients suffering from infarction and those recovering from angioplasty during flu season. This response could be related to a humoral immune response with positive consequences during flu seasons.
Key Words: myocardial infarction • infection • immune system • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  A. Ciszewski, Z. T. Bilinska, L. B. Brydak, C. Kepka, M. Kruk, M. Romanowska, E. Ksiezycka, J. Przyluski, W. Piotrowski, R. Maczynska, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study Eur. Heart J., June 1, 2008; 29(11): 1350 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Clayton, M. Thompson, and T. W. Meade Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database Eur. Heart J., January 1, 2008; 29(1): 96 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. S. Packard, S. Schlegel, D. Senouf, F. Burger, P. Sigaud, T. Perneger, C.-A. Siegrist, and F. Mach Atorvastatin Treatment and Vaccination Efficacy J. Clin. Pharmacol., August 1, 2007; 47(8): 1022 - 1027. [Full Text] [PDF]
|
|
|
|
|
|
M. Madjid, C. C. Miller, V. V. Zarubaev, I. G. Marinich, O. I. Kiselev, Y. V. Lobzin, A. E. Filippov, and S. W. Casscells III Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects Eur. Heart J., May 2, 2007; 28(10): 1205 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Davis, K. Taubert, A. L. Benin, D. W. Brown, G. A. Mensah, L. M. Baddour, S. Dunbar, and H. M. Krumholz Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1498 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Davis, K. Taubert, A. L. Benin, D. W. Brown, G. A. Mensah, L. M. Baddour, S. Dunbar, and H. M. Krumholz Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Association of Critical Care Nurses, the American Association of Heart Failure Nurses, the American Diabetes Association, the Association of Black Cardiologists, Inc., the Heart Failure Society of America, and the Preventive Cardiovascular Nurses Association.: The American Academy of Nurse Practitioners supports the recommendations of this scientific advisory.: This science advisory is consistent with the recommendations of the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices. Circulation, October 3, 2006; 114(14): 1549 - 1553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Grau, B. Fischer, C. Barth, P. Ling, C. Lichy, and F. Buggle Influenza Vaccination Is Associated With a Reduced Risk of Stroke Stroke, July 1, 2005; 36(7): 1501 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nilsson, G. K. Hansson, and P. K. Shah Immunomodulation of Atherosclerosis: Implications for Vaccine Development Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 18 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Gurfinkel, R. Leon de la Fuente, O. Mendiz, and B. Mautner Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study: One-year follow-up Eur. Heart J., January 1, 2004; 25(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Madjid, M. Naghavi, S. Litovsky, and S. W. Casscells Influenza and Cardiovascular Disease: A New Opportunity for Prevention and the Need for Further Studies Circulation, December 2, 2003; 108(22): 2730 - 2736. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sorokin, M. Charlson, and O. W. Isom Care after Coronary-Artery Bypass Surgery N. Engl. J. Med., July 17, 2003; 349(3): 307 - 307. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Madjid, S. Lillibridge, P. Mirhaji, and W. Casscells Influenza as a bioweapon J R Soc Med, July 1, 2003; 96(7): 345 - 346. [Full Text] [PDF]
|
|
|
|
|
|
K. L. Nichol, J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly N. Engl. J. Med., April 3, 2003; 348(14): 1322 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zahn, S. Schneider, B. Frilling, K. Seidl, U. Tebbe, M. Weber, M. Gottwik, E. Altmann, F. Seidel, J. Rox, et al. Antibiotic Therapy After Acute Myocardial Infarction: A Prospective Randomized Study Circulation, March 11, 2003; 107(9): 1253 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Van Lenten, A. C. Wagner, G.M. Anantharamaiah, D. W. Garber, M. C. Fishbein, L. Adhikary, D. P. Nayak, S. Hama, M. Navab, and A. M. Fogelman Influenza Infection Promotes Macrophage Traffic Into Arteries of Mice That Is Prevented by D-4F, an Apolipoprotein A-I Mimetic Peptide Circulation, August 27, 2002; 106(9): 1127 - 1132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Flu Shots After Angioplasty and After MI Journal Watch Cardiology, July 26, 2002; 2002(726): 5 - 5. [Full Text]
|
|
|
|
 |
|
 Influenza Vaccination Decreases Acute Coronary Syndromes Journal Watch Infectious Diseases, July 12, 2002; 2002(712): 8 - 8. [Full Text]
|
|